Pretreatment Thrombocytosis as a Prognostic Factor in Women with Gynecologic Malignancies: a Meta-analysis

Yu, Min; Liu, Lei; Zhang, Bing-Lan; Chen, Qi; Ma, Xue-Lei; Wu, Yu-Ke; Liang, Chun-Shui; Niu, Zhi-Min; Qin, Xin; Niu, Ting

추천

검색

자료유형: 학술저널

저자정보: Yu, Min (Department of Cancer Center, State Key Laboratory of Biotherapy) Liu, Lei (Department of Cancer Center, State Key Laboratory of Biotherapy) Zhang, Bing-Lan (Department of Cancer Center, State Key Laboratory of Biotherapy) Chen, Qi (Department of Cancer Center, State Key Laboratory of Biotherapy) Ma, Xue-Lei (Department of Cancer Center, State Key Laboratory of Biotherapy) Wu, Yu-Ke (Department of Cancer Center, State Key Laboratory of Biotherapy) Liang, Chun-Shui (Department of Cancer Center, State Key Laboratory of Biotherapy) Niu, Zhi-Min (Department of Cancer Center, State Key Laboratory of Biotherapy) Qin, Xin (Department of Cancer Center, State Key Laboratory of Biotherapy) Niu, Ting (Department of Hematology, West China Hospital, Sichuan University)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제13권 제12호

발행연도: 2012.1

수록면: 6,077 - 6,081 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: This study was performed to analyze the prognostic implications of pretreatment or preoperative thrombocytosis in women with gynecologic malignancies. Material and Methods: We surveyed 2 medical databases, PubMed and EMBASE, to identified all relevant studies. A total of 14 (n=3,490) that evaluated the link between thrombocytosis and 5-year survival were included. REVMAN version 5.1 was used for our analysis and publication bias was evaluated using the Begg's funnel plot and tested by STATA 11.0. Risk ratios (RRs) with 95% confidence intervals (CIs) generated by the random effect model were used to assess the strength of any association. Results: 709(20.3%) of the 3,490 patients exhibited thrombocytosis (platelet counts > $400{\times}10^9/L$) at primary diagnosis, and their mortality was 1.62-fold higher compared with the others (RR=1.62, 95%CI=[1.28-2.05], p<0.0001). Thrombocytosis failed to have a stronger effect on the survival of advanced patients of stages III to IV in our study (n=478, RR=1.29, 95% CI=[1.13-1.48], p=0.0003), nor in women with cervical cancer in stage IB (n=1371, RR=1.73, 95% CI=[1.71-2.58], p=0.007). In addition, when adjusted for different carcinoma, it was associated with worse prognosis for all except the ones with vulvar cancer (n=201, RR=0.43, 95% CI=[0.14-1.29], p=0.13). Conclusions: This meta-analysis indicated that thrombocytosis might be associated with a worse prognosis for patients with gynecologic malignancies but without specificity or sensitivity for the ones in advanced stage. When adjusted for different gynecologic malignancies, it showed a significant effect on survival of all except vulvar cancers.

#Thrombocytosis #gynecologic malignancies #meta #analysis #prognosis

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요